Fresenius Medical Care Ag & CO Kgaa (FME.D.DX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [DXE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [DXE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 366,256 | 387,000 | 512,443 | 425,934 | N/A |
| Income taxes - deferred | N/A | N/A | -44,365 | -32,633 | N/A |
| Accounts receivable | 592,845 | -23,000 | -552,721 | -75,809 | -85,000 |
| Accounts payable and accrued liabilities | N/A | N/A | 126,599 | -26,646 | N/A |
| Other Working Capital | 914,094 | -186,000 | -420,831 | 122,243 | N/A |
| Other Operating Activity | -888,753 | 264,000 | 506,183 | 305,977 | 845,000 |
| Operating Cash Flow | $984,442 | $442,000 | $127,308 | $719,066 | $760,000 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -169,164 | -153,000 | -129,494 | -238,868 | N/A |
| Net Acquisitions | N/A | N/A | 40,579 | 132,518 | N/A |
| Purchase Of Investment | N/A | N/A | -188 | -4,226 | N/A |
| Sale Of Investment | N/A | N/A | 20,736 | 14,075 | N/A |
| Other Investing Activity | 769,419 | -153,000 | 0 | 0 | 0 |
| Investing Cash Flow | $600,255 | $-306,000 | $-68,367 | $-96,501 | $N/A |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | -344,854 | -133,712 | N/A |
| Debt Issued | N/A | N/A | 9,288 | 207,310 | N/A |
| Debt Repayment | N/A | N/A | -178,570 | -753,634 | N/A |
| Other Financing Activity | 0 | 0 | 224,479 | -65,618 | 0 |
| Financing Cash Flow | $N/A | $N/A | $-289,657 | $-745,654 | $N/A |
| Exchange Rate Effect | N/A | N/A | -4,514 | -24,045 | N/A |
| Beginning Cash Position | N/A | N/A | 1,427,225 | 1,574,359 | N/A |
| End Cash Position | N/A | N/A | 1,191,995 | 1,427,225 | N/A |
| Net Cash Flow | $N/A | $N/A | $-230,716 | $-123,089 | $N/A |
| Free Cash Flow | |||||
| Operating Cash Flow | 984,442 | 442,000 | 127,308 | 719,066 | 760,000 |
| Capital Expenditure | N/A | -312,000 | -133,900 | -250,278 | -271,000 |
| Free Cash Flow | 984,442 | 130,000 | -6,592 | 468,788 | 489,000 |